718 related articles for article (PubMed ID: 12710998)
1. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
Wietzke JA; Welsh J
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.
Wietzke JA; Ward EC; Schneider J; Welsh J
Mol Cell Endocrinol; 2005 Jan; 230(1-2):59-68. PubMed ID: 15664452
[TBL] [Abstract][Full Text] [Related]
3. Phytoestrogens regulate transcription and translation of vitamin D receptor in colon cancer cells.
Gilad LA; Tirosh O; Schwartz B
J Endocrinol; 2006 Nov; 191(2):387-98. PubMed ID: 17088408
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor.
Gehm BD; McAndrews JM; Chien PY; Jameson JL
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14138-43. PubMed ID: 9391166
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells.
Maggiolini M; Bonofiglio D; Marsico S; Panno ML; Cenni B; Picard D; Andò S
Mol Pharmacol; 2001 Sep; 60(3):595-602. PubMed ID: 11502892
[TBL] [Abstract][Full Text] [Related]
6. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG
J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
8. Resistance of HBL100 human breast epithelial cells to vitamin D action.
Agadir A; Lazzaro G; Zheng Y; Zhang XK; Mehta R
Carcinogenesis; 1999 Apr; 20(4):577-82. PubMed ID: 10223184
[TBL] [Abstract][Full Text] [Related]
9. Flavonoid effects relevant to cancer.
Brownson DM; Azios NG; Fuqua BK; Dharmawardhane SF; Mabry TJ
J Nutr; 2002 Nov; 132(11 Suppl):3482S-3489S. PubMed ID: 12421874
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
11. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
12. Differential response to phytoestrogens in endocrine sensitive and resistant breast cancer cells in vitro.
Limer JL; Parkes AT; Speirs V
Int J Cancer; 2006 Aug; 119(3):515-21. PubMed ID: 16506217
[TBL] [Abstract][Full Text] [Related]
13. Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells.
Sakamoto T; Horiguchi H; Oguma E; Kayama F
J Nutr Biochem; 2010 Sep; 21(9):856-64. PubMed ID: 19800779
[TBL] [Abstract][Full Text] [Related]
14. Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elements.
Swami S; Krishnan AV; Peng L; Lundqvist J; Feldman D
Endocr Relat Cancer; 2013 Aug; 20(4):565-77. PubMed ID: 23744764
[TBL] [Abstract][Full Text] [Related]
15. Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogen biosynthesis, and metabolism.
Brueggemeier RW; Gu X; Mobley JA; Joomprabutra S; Bhat AS; Whetstone JL
Ann N Y Acad Sci; 2001 Dec; 948():51-66. PubMed ID: 11795395
[TBL] [Abstract][Full Text] [Related]
16. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the potential activity of major dietary compounds as selective estrogen receptor modulators in two distinct cell models for proliferation and differentiation.
Lecomte S; Lelong M; Bourgine G; Efstathiou T; Saligaut C; Pakdel F
Toxicol Appl Pharmacol; 2017 Jun; 325():61-70. PubMed ID: 28396216
[TBL] [Abstract][Full Text] [Related]
18. The 3-epi- and 24-oxo-derivatives of 1alpha,25 dihydroxyvitamin D(3) stimulate transcription through the vitamin D receptor.
Messerlian S; Gao X; St-Arnaud R
J Steroid Biochem Mol Biol; 2000; 72(1-2):29-34. PubMed ID: 10731635
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.
Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG
Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583
[TBL] [Abstract][Full Text] [Related]
20. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
